TABLE 2.

Outcome, measures, and advices for the 183 patients

Diagnosis (No. of pts)	Psoriasis/PsA (126)	Acne (10)	AD (11)	HS (11)	Autoimmune blistering disease (9)	Other autoimmune skin diseases (16)
Mean call duration of the first call	9 minutes	8 minutes	10 minutes	7 minutes	7 minutes	8 minutes
No. of calls per patient range (mean)	1‐6 (1.5)	1‐4 (2.3)	1‐4 (2.7)	1‐3 (1.2)	1‐4 (1.2)	1‐3 (1.2)
No. of e‐mails per patient range (mean)	0‐4 (0.8)	1‐4 (1.6)	1‐4 (1.2)	1–2 (1.1)	1‐3 (1.2)	0‐2 (0.8)
Systemic therapy	Continue: 110 Dose reduction: 3 MTX Switch: 1 BRO to RIS Start therapy: 1 TIL Withdrawal: 11 pts, 6 MTX, 1 ACI, 1 ADA, 2 GUS, 1 CSA	Continue: 10 pts, Dose‐change isotretinoin: 2 pts	Continue: 9 Start therapy: 1 (DUPI)	Continue: 11	Continue: 9	Continue: 16
Advice for COVID‐19	2 pts confirmed (MTX, GUS), 1 death (GUS)	None	None	None	None	None
No. of e‐lab prescriptions	65	10	7	4	5	6
No. of e‐drug prescriptions	50	10	6	4	9	16
E‐visit‐request for other specialties	2 (Rheumatology)	0	1	0	0	0
Reschedule of next appointment	126	10	11	11	9	16